Gulaver, Terissa T.
HRN: 24-19-27 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/06/2023
CEFTRIAXONE 1G (VIAL)
12/06/2023
12/12/2023
IVT
2gms
Q24
Complicated Uti, Dm Ty
Waiting Final Action
Indication: Empiric Type of Infection: Urinary Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes